Abstract
Despite the prevalence and health impact of olfactory dysfunction (OD), therapeutic options remain limited. One potential therapy is olfactory training (OT), where patients repeatedly sniff a small set of odors over several weeks with the goal of improving olfactory function. Although double-blinded, placebo-controlled clinical trials supporting the efficacy of OT are lacking, anecdotal evidence suggests that the procedure is widely recommended to patients with anosmia or other olfactory disorders. To better understand the adoption of OT in clinical practice, we recruited a convenience sample of 95 rhinologists and other otolaryngologists to complete an online survey that assessed how often, and under what conditions, they recommend OT to their patients with OD. Our survey revealed that the majority of responding otolaryngologists (93.7%) routinely recommend OT. Further, they recommend OT more often for quantitative than for qualitative disorders, and most frequently for post-viral and idiopathic OD etiologies. These findings support the perception that OT is commonly recommended in otolaryngological practice for the treatment of OD.
Key Points
Most surveyed otolaryngologists routinely recommend olfactory training (OT).
OT is recommended more often for quantitative than qualitative olfactory dysfunction (OD).
OT is most often recommended for post-viral and idiopathic OD etiologies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by R01DC21604 (SDM) and the University of Virginia Department of Otolaryngology, Head and Neck Surgery and by the University of Virginia School of Medicine Medical School Summer Research Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the University of Virginia (UVA) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: This study was supported by R01DC21604 (SDM) and the University of Virginia Department of Otolaryngology–Head and Neck Surgery and by the University of Virginia School of Medicine Medical School Summer Research Program
Conflicts of interest: The authors declare no conflicts of interest
Data Availability
All data produced in the present work are contained in the manuscript.
